GH Research PLC (GHRS)
9.59
-0.03
(-0.31%)
USD |
NASDAQ |
Nov 22, 15:02
GH Research Total Assets (Quarterly): 199.61M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 199.61M |
| June 30, 2024 | 206.98M |
| March 31, 2024 | 217.58M |
| December 31, 2023 | 226.30M |
| September 30, 2023 | 232.57M |
| June 30, 2023 | 240.27M |
| March 31, 2023 | 249.26M |
| December 31, 2022 | 254.36M |
| Date | Value |
|---|---|
| September 30, 2022 | 260.12M |
| June 30, 2022 | 266.32M |
| March 31, 2022 | 273.54M |
| December 31, 2021 | 279.92M |
| September 30, 2021 | 285.63M |
| June 30, 2021 | 292.82M |
| March 31, 2021 | 5.556M |
| December 31, 2020 | 5.912M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
5.556M
Minimum
Mar 2021
292.82M
Maximum
Jun 2021
218.55M
Average
244.77M
Median
Total Assets (Quarterly) Benchmarks
| Amarin Corp PLC | 750.62M |
| Jazz Pharmaceuticals PLC | 12.26B |
| Prothena Corp PLC | 595.25M |
| Iterum Therapeutics PLC | 19.62M |
| Mural Oncology PLC | 203.27M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 10.24M |
| Shareholders Equity (Quarterly) | 189.37M |